Skip to main content
. 2021 Jun 18;10(6):739. doi: 10.3390/antibiotics10060739

Table 3.

Pharmacokinetic estimates for the final models of rifampin, isoniazid, pyrazinamide, and ethambutol. Ka, absorption rate constant; V, volume of distribution in the central compartment; V2, volume of distribution of the peripheral compartment; Cl, systemic clearance; Cl2, intercompartmental clearance; Tlag, lag-time. %CV, coefficient of variation or precision; IIV, inter-individual variation.

Drug Parameter Final Model
Estimate (%CV) IIV (Shrinkage)
Rifampin Ka (1/h) 0.3 (13.5) 0.01 (0.9)
V (L) 25.3 (33.3) 3.2 (0.2)
Cl (L/h) 0.1 (49.6) 0.2 (0.3)
Tlag (h) 0.9 (9.1) 0.003 (0.8)
Isoniazid Ka (1/h) 0.9 (0.9) 0.9 (0.3)
V (L) 2.9 (3) 0.07 (0.6)
V2 (L) 32.5 (5.7) 0.5 (0.7)
Cl (L/h) 9.2 (8.7) 0.8 (0.1)
Cl2 (L/h) 9.6 (3) 0.0001 (0.9)
Tlag (h) 0.4 (8.6) 0.5 (0.5)
Pyrazinamide Ka (1/h) 0.08 (13) 0.1-0.11
V (L) 1.5 (16.3) 0.9 (0.4)
Cl (L/h) 2.6 (14.5) 0.4 (0.05)
Tlag (h) 0.2 (7.1) 1.3 (0.4)
Ethambutol Ka (1/h) 0.15 (21.8) 0.6 (0.4)
V (L) 75.17 (23.7) 0.4 (0.1)
Cl (L/h) 51.6 (12.2) 0.3 (0.3)
Tlag (h) 0.4 (12.3) 0.6 (0.4)